Relay Therapeutics to Participate in Upcoming Investor Conferences
Relay Therapeutics (Nasdaq: RLAY) has announced its participation in four upcoming investor conferences in November and December 2024. The company will participate in fireside chats at the Guggenheim Healthcare Innovation Conference (Nov 13), Stifel Healthcare Conference (Nov 18), Jefferies London Healthcare Conference (Nov 20), and Citizens JMP Hematology and Oncology Summit (Dec 2). All sessions will be webcast live and accessible through Relay's website, with recordings available for 30 days after each event.
Relay Therapeutics (Nasdaq: RLAY) ha annunciato la sua partecipazione a quattro prossime conferenze per investitori nei mesi di novembre e dicembre 2024. L'azienda parteciperà a chat informali durante il Guggenheim Healthcare Innovation Conference (13 novembre), il Stifel Healthcare Conference (18 novembre), il Jefferies London Healthcare Conference (20 novembre), e il Citizens JMP Hematology and Oncology Summit (2 dicembre). Tutte le sessioni saranno trasmesse in diretta e accessibili attraverso il sito web di Relay, con registrazioni disponibili per 30 giorni dopo ciascun evento.
Relay Therapeutics (Nasdaq: RLAY) ha anunciado su participación en cuatro próximas conferencias para inversores en noviembre y diciembre de 2024. La compañía participará en charlas informales en la Guggenheim Healthcare Innovation Conference (13 de noviembre), en la Stifel Healthcare Conference (18 de noviembre), en la Jefferies London Healthcare Conference (20 de noviembre), y en el Citizens JMP Hematology and Oncology Summit (2 de diciembre). Todas las sesiones se transmitirán en vivo y serán accesibles a través del sitio web de Relay, con grabaciones disponibles durante 30 días después de cada evento.
릴레이 테라퓨틱스 (Nasdaq: RLAY)는 2024년 11월 및 12월에 예정된 네 가지 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 구겐하임 헬스케어 혁신 컨퍼런스 (11월 13일), 스티펠 헬스케어 컨퍼런스 (11월 18일), 제퍼리스 런던 헬스케어 컨퍼런스 (11월 20일), 시티즌 JMP 혈액학 및 종양학 정상 회담 (12월 2일)에서 편안한 대화를 나눌 예정입니다. 모든 세션은 라이브로 방송되며 릴레이 웹사이트를 통해 액세스할 수 있으며, 각 이벤트 후 30일 동안 녹화본이 제공됩니다.
Relay Therapeutics (Nasdaq: RLAY) a annoncé sa participation à quatre prochaines conférences pour investisseurs en novembre et décembre 2024. La société participera à des discussions informelles lors de la Guggenheim Healthcare Innovation Conference (13 novembre), de la Stifel Healthcare Conference (18 novembre), de la Jefferies London Healthcare Conference (20 novembre) et du Citizens JMP Hematology and Oncology Summit (2 décembre). Toutes les sessions seront diffusées en direct et accessibles via le site Web de Relay, avec des enregistrements disponibles pendant 30 jours après chaque événement.
Relay Therapeutics (Nasdaq: RLAY) hat die Teilnahme an vier bevorstehenden Investorenkonferenzen im November und Dezember 2024 bekannt gegeben. Das Unternehmen wird an informellen Gesprächen auf der Guggenheim Healthcare Innovation Conference (13. November), der Stifel Healthcare Conference (18. November), der Jefferies London Healthcare Conference (20. November) und dem Citizens JMP Hämatologie- und Onkologie-Gipfel (2. Dezember) teilnehmen. Alle Sitzungen werden live übertragen und sind über die Website von Relay zugänglich, mit Aufzeichnungen, die 30 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in the following upcoming fireside chats:
- Guggenheim Healthcare Innovation Conference on Wednesday, November 13, 2024 at 10:00 a.m. ET
- Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 10:55 a.m. ET
- Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 6:30 a.m. ET (11:30 a.m. GMT)
- The Citizens JMP Hematology and Oncology Summit, taking place virtually on Monday, December 2, 2024 at 1:30 p.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.
Contact:
Megan Goulart
617-545-5526
mgoulart@relaytx.com
Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com
FAQ
What investor conferences will Relay Therapeutics (RLAY) attend in November 2024?
When is Relay Therapeutics (RLAY) presenting at the Citizens JMP Summit?
How long will Relay Therapeutics (RLAY) conference webcasts be available?
Where can I watch Relay Therapeutics (RLAY) investor conference presentations?
